O'Donovan N - Search Results

1

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.

Canonici A, Qadir Z, Conlon NT, Collins DM, O'Brien NA, Walsh N, Eustace AJ, O'Donovan N, Crown J. Canonici A, et al. Invest New Drugs. 2018 Aug;36(4):581-589. doi: 10.1007/s10637-017-0556-7. Epub 2018 Feb 2. Invest New Drugs. 2018. PMID: 29396630

2

Mammaglobin a: a promising marker for breast cancer.

O'Brien N, Maguire TM, O'Donovan N, Lynch N, Hill AD, McDermott E, O'Higgins N, Duffy MJ. O'Brien N, et al. Clin Chem. 2002 Aug;48(8):1362-4. Clin Chem. 2002. PMID: 12142396 No abstract available.

3

Caspase 3 in breast cancer.

O'Donovan N, Crown J, Stunell H, Hill AD, McDermott E, O'Higgins N, Duffy MJ. O'Donovan N, et al. Clin Cancer Res. 2003 Feb;9(2):738-42. Clin Cancer Res. 2003. PMID: 12576443

4

Mammaglobin a in breast cancer: existence of multiple molecular forms.

O'Brien NA, O'Donovan N, Ryan B, Hill AD, McDermott E, O'Higgins N, Duffy MJ. O'Brien NA, et al. Int J Cancer. 2005 Apr 20;114(4):623-7. doi: 10.1002/ijc.20780. Int J Cancer. 2005. PMID: 15609337

5

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.

Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill AD, McDermott E, O'Higgins N, Duffy MJ. Ryan B, et al. Br J Cancer. 2005 Jan 17;92(1):120-4. doi: 10.1038/sj.bjc.6602314. Br J Cancer. 2005. PMID: 15611790 Free PMC article.

6

EGFR and HER-2 antagonists in breast cancer.

O'Donovan N, Crown J. O'Donovan N, et al. Anticancer Res. 2007 May-Jun;27(3A):1285-94. Anticancer Res. 2007. PMID: 17593621 Free article. Review.

7

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.

Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N. Glynn SA, et al. BMC Cancer. 2008 Jan 16;8:9. doi: 10.1186/1471-2407-8-9. BMC Cancer. 2008. PMID: 18199328 Free PMC article.

8

Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.

O'Brien N, O'Donovan N, Foley D, Hill AD, McDermott E, O'Higgins N, Duffy MJ. O'Brien N, et al. Tumour Biol. 2007;28(6):312-7. doi: 10.1159/000115527. Epub 2008 Feb 5. Tumour Biol. 2007. PMID: 18253069

9

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.

Eustace AJ, Crown J, Clynes M, O'Donovan N. Eustace AJ, et al. J Transl Med. 2008 Sep 29;6:53. doi: 10.1186/1479-5876-6-53. J Transl Med. 2008. PMID: 18823558 Free PMC article.

10

Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells.

Walsh N, Dowling P, O'Donovan N, Henry M, Meleady P, Clynes M. Walsh N, et al. J Proteomics. 2008 Dec 2;71(5):561-71. doi: 10.1016/j.jprot.2008.09.002. Epub 2008 Sep 25. J Proteomics. 2008. PMID: 18848913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters